Price target
4.910.000.00%
The 10 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 15 analysts giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
EDIT EPS for the last quarter is −0.28 USD despite the estimation of −0.30 USD. In the next quarter EPS is expected to reach −0.23 USD. Track more of Editas Medicine, Inc. financials and stay on top of what is up with the company.
In the next quarter Editas Medicine, Inc. revenue is expected to reach 8.35 M USD. Check out Editas Medicine, Inc. revenue and earnings and make informed decisions.
According to analysts, EDIT price target is 4.91 USD with a max estimate of 13.00 USD and a min estimate of 1.00 USD. Check if this forecast comes true in a year, meanwhile watch Editas Medicine, Inc. stock price chart and keep track of the current situation with EDIT news and stock market news.
We've gathered opinions of 15 analysts rating EDIT stock in the past 3 months. After counting all points of view, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.